Kyobo 8 Special Purpose Acquisition Company - Asset Resilience Ratio
Kyobo 8 Special Purpose Acquisition Company (307280) has an Asset Resilience Ratio of 9.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how Kyobo 8 Special Purpose Acquisition Company's Asset Resilience Ratio has changed over time. See 307280 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Kyobo 8 Special Purpose Acquisition Company's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Kyobo 8 Special Purpose Acquisition Comp.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩4.83 Billion | 9.73% |
| Total Liquid Assets | ₩4.83 Billion | 9.73% |
Asset Resilience Insights
- Limited Liquidity: Kyobo 8 Special Purpose Acquisition Company maintains only 9.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Kyobo 8 Special Purpose Acquisition Company Industry Peers by Asset Resilience Ratio
Compare Kyobo 8 Special Purpose Acquisition Company's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Zhejiang Gongdong Medical Technology Co Ltd
SHG:605369 |
Medical Instruments & Supplies | 4.24% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual Asset Resilience Ratio data for Kyobo 8 Special Purpose Acquisition Company.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.91% | ₩7.10 Billion ≈ $4.81 Million |
₩47.63 Billion ≈ $32.28 Million |
+6.00pp |
| 2024-12-31 | 8.90% | ₩3.67 Billion ≈ $2.49 Million |
₩41.27 Billion ≈ $27.97 Million |
-3.96pp |
| 2023-12-31 | 12.87% | ₩5.52 Billion ≈ $3.74 Million |
₩42.90 Billion ≈ $29.08 Million |
-0.87pp |
| 2022-12-31 | 13.73% | ₩5.35 Billion ≈ $3.62 Million |
₩38.93 Billion ≈ $26.38 Million |
-- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more